Sibling Group Holdings, Inc. Stock Other OTC
Equities
SIBE
US8257841010
Biotechnology & Medical Research
Sales 2014 | 0.15 0.21 | Sales 2015 | 2.21 3.02 | Capitalization | 12.15M 16.63M |
---|---|---|---|---|---|
Net income 2014 | -1M -1.37M | Net income 2015 | -7M -9.58M | EV / Sales 2014 | 26,727,146 x |
Net Debt 2014 | 110K 151K | Net cash position 2015 | 5.29M 7.23M | EV / Sales 2015 | 3,109,835 x |
P/E ratio 2014 |
-1.83
x | P/E ratio 2015 |
-0.74
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 94.26% |
Managers | Title | Age | Since |
---|---|---|---|
Jihad Mohammad
CEO | Chief Executive Officer | - | 23-09-19 |
Hussein A. Anani
CEO | Chief Executive Officer | - | 20-12-31 |
Mouktar Makkouk
DFI | Director of Finance/CFO | - | 23-09-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jihad Mohammad
CEO | Chief Executive Officer | - | 23-09-19 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |